The aberrant FLT3-ITD oncogene signal constitutively activates the above signaling pathways, which subsequently inhibit cell apoptosis, promote cell proliferation and survival via regulation of apoptosis-related genes, thereby leading to the initiation and development of AML [34–37]. Here, FLT3 is linked to acute myeloid leukemia.